142
Views
13
CrossRef citations to date
0
Altmetric
Special Report

The rise of hemodialysis machines: new technologies in minimizing cardiovascular complications

, , &
Pages 155-164 | Published online: 10 Jan 2014

References

  • Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med.351, 1296–1305 (2004).
  • Culleton BF, Larson MG, Wilson PW et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int.56, 2214–2219 (1999).
  • Goodkin DA, Bragg-Gresham JL, Koenig KG et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States; the Dialysis Outcomes and Practice Patterns Study (DOPPS). J. Am. Soc. Nephrol.14, 3270–3277 (2003).
  • Foley RN. Cardiac disease in chronic uremia: can it explain the reverse epidemiology of hypertension and survival in dialysis patients? Semin. Dial.17, 275–278 (2004).
  • Barret BJ. Reducing the burden of cardiovascular disease in patients on dialysis. Dial. Transplant.31, 155–163 (2002).
  • Honda H, Qureshi AR, Heimburger O et al. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am. J. Kidney Dis.47(1), 139–148 (2006).
  • Panichi V, Rizza GM, Paoletti S, Bigazzi R et al. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study. Nephrol. Dial. Transplant.23(7), 2337–2343 (2008).
  • Daugirdas JT. Pathophysiology of dialysis hypotension: an update. Am. J. Kidney Dis.38, S11–S17 (2001).
  • Ozkahya M, Ok E, Toz H et al. Long-term survival rates in haemodialysis patients treated with strict volume control. Nephrol. Dial. Transplant.21(12), 3506–3513 (2006).
  • Weinreich T, De los Ríos T, Gauly A, Passlick-Deetjen J. Effects of an increase in time vs. frequency on cardiovascular parameters in chronic hemodialysis patients. Clin. Nephrol.66(6), 433–439 (2006).
  • Culleton BF, Walsh M, Klarenbach SW et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA298(11), 1291–1299 (2007).
  • Moissl U, Wabel P, Chamney P et al. Body fluid volume determination via body composition spectroscopy in health and disease. Physiol. Meas.27, 921– 933 (2006).
  • Chamney PW, Krämer M, Rode C, Wizemann V. A new technique for establishing dry weight in hemodialysis patients via whole body bioimpedance. Kidney Int.61, 2250–2258 (2002).
  • Wizemann V, Wabel P, Chamney P et al. The mortality risk of overhydration in haemodialysis patients. Nephrol. Dial. Transplant.24(5), 1574–1579 (2009).
  • Maggiore Q, Pizzarelli F, Zoccali C et al. Effect of extracorporeal blood cooling on dialytic arterial hypotension. Proc. Eur. Dial. Transplant. Assoc.18, 597–602 (1981).
  • Barth C, Boer W, Garzoni D et al. Characteristics of hypotensionprone haemodialysis patients: is there a critical relative blood volume? Nephrol. Dial. Transplant.18, 1353–1360 (2003).
  • Andrulli S, Colzani S, Mascia F et al. The role of blood volume reduction in the genesis of intradialytic hypotension. Am. J. Kidney Dis.40, 1244–1254 (2002).
  • Johner C, Chamney PW, Schneditz D, Kraemer M. Evaluation of an ultrasonic blood volume monitor. Nephrol. Dial. Transplant.13, 2098–2103 (1998).
  • Garzoni D, Keusch G, Kleinoeder T et al. Reduced complications during hemodialysis by automatic blood volume controlled ultrafiltration. Int. J. Artif. Organs30, 16–24 (2007).
  • Barth C, Boer W, Garzoni D et al. Characteristics of hypotensionprone haemodialysis patients: is there a critical relative blood volume? Nephrol. Dial. Transplant.18, 1353–1360 (2003).
  • Reddan DN, Szczech LA, Hasselblad V et al. Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial. J. Am. Soc. Nephrol.16(7), 2162–2169 (2005).
  • Gabrielli D, Kristal B, Katzarski K et al. Improved intradialytic stability during haemodialysis. with blood volume-controlled ultrafiltration. J. Nephrol.22, 232–240 (2009).
  • Stewart WK, Fleming LW, Manuel MA. Benefits obtained by the use of high sodium dialysate during maintenance haemodialysis. Proc. Eur. Dial. Transplant. Assoc.9, 111–118 (1972).
  • Port FK, Johnson WJ, Klass DW. Prevention of dialysis disequilibrium syndrome by use of high sodium concentration in the dialysate. Kidney Int.3(5), 327–333 (1973).
  • Funck-Brentano JL. Sodium-free water clearance in hemodialysis. Artif. Organs5(1), 51–53 (1981).
  • Stiller S, Bonnie-Schorn E, Grassmann A et al. A critical review of sodium profiling for hemodialysis. Semin. Dial.14(5), 337–347 (2001).
  • Locatelli F, Buoncristiani U, Canaud B et al. Haemodialysis with on-line monitoring equipment: tools or toys? Nephrol. Dial. Transplant.20, 22–33 (2005).
  • Gross M, Maierhofer A, Tetta C, Sénecal L, Canaud B. Online clearance measurement in high-efficiency hemodiafiltration. Kidney Int.72(12), 1550–1553 (2007).
  • Sperschneider H, Schoeppe R, Schneider S, Stein G. [The impact of different bicarbonate profiles on phosphate elimination in haemodialysis]. Dial. J.61, 92–98 (1998).
  • Morrison G, Michelson EL, Brown S, Morganroth J. Mechanism and prevention of cardiac arrhythmias in chronic hemodialysis patients. Kidney Int.17(6), 811–819 (1980).
  • Redaelli B, Locatelli F, Limido D et al. Effect of a new model of hemodialysis potassium removal on the control of ventricular arrhythmias. Kidney Int.50(2), 609–617 (1996).
  • Redaelli B. Electrolyte modelling in haemodialysis – potassium. Nephrol. Dial. Transplant.11(Suppl. 2), 39–41 (1996).
  • Santoro A, Mancini E, Gaggi R et al. Electrophysiological response to dialysis: the role of dialysate potassium content and profiling. Contrib. Nephrol.149, 295–305 (1995).
  • Henderson LW. The beginning of clinical hemofiltration: a personal account. ASAIO49(5), 513–517 (2003).
  • Santoro A, Guarnieri F, Ferramosca E, Grandi F. Acetate-free biofiltration. Contrib. Nephrol.158, 138–152 (2007).
  • Wratten ML, Ghezzi PM. Hemodiafiltration with endogenous reinfusion. Contrib. Nephrol.158, 94–102 (2007).
  • Santoro A, Mancini E, Zucchelli P. The impact of hemofiltration on the systemic cardiovascular response. Nephrol. Dial. Transplant.15(Suppl. 2), 49–54 (2000).
  • Santoro A, Mancini E, Bolzani R et al. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial. Am. J. Kidney Dis.52(3), 507–518 (2008).
  • Henderson LW, Sanfelippo ML, Beans E. ‘On line’ preparation of sterile pyrogen-free electrolyte solution. Trans. Am. Soc. Artif. Intern. Organs24, 465–467 (1978).
  • Ward RA. Ultrapure dialysate: a desirable and achievable goal for routine hemodialysis. Semin. Dial.13(6), 378–380 (2000).
  • Penne EL, Wisser L, van den Dorpel MA et al. Microbiological quality and quality control of purified water and ultrapure dialysis fluids for on-line hemodiafilttration in routine clinical practice. Kidney Int.76, 665–672 (2009).
  • Canaud BJ. Changing paradigms of renal replacement therapy in chronic kidney disease patients: ultrapure dialysis fluid and high-efficiency hemodiafiltration for all? Kidney Int.76(6), 591–593 (2009).
  • Tetta C, David S, Marcelli D et al. Clinical effects of online dialysate and infusion fluids. Hemodial. Int.10(Suppl. 1), S60–S66 (2006).
  • Lederer SR, Schiffl H. Ultrapure dialysis fluid lowers the cardiovascular morbidity in patients on maintenance hemodialysis by reducing continuous microinflammation. Nephron91(3), 452–455 (2002).
  • Polaschegg HD. Automatic, noninvasive intradialytic clearance measurment. Int J. Artif. Organs16(4), 185–191 (1993).
  • Boda D, Gal G, Eck E, Kiss E. Ultraviolettspektrophotometrische untersuchung des serumdialysats von chronisch intermittierend mit der künstlichen niere behandelten patienten. Zschr. Urol.70, 345–349 (1977).
  • Gál G, Gróf J. Continuous UV photometric monitoring of the efficiency of hemodialysis. Int. J. Artif. Organs6, 338–341 (1980).
  • Depner TA, Keshaviah PR, Ebben JP et al. Multicenter clinical validation of an on-line monitor of dialysis adequacy. J. Am. Soc. Nephrol.7(3), 464–471 (1996).
  • Eddy CV, Arnold MA. Near-infrared spectroscopy for measuring urea in hemodialysis fluids. Clin. Chem.47(7), 1279–1286 (2001).
  • Olesberg JT, Arnold MA, Flanigan MJ. Online measurement of urea concentration in spent dialysate during hemodialysis. Clin. Chem.50(1), 175–181 (2004).
  • Uhlin F, Fridolin I, Lindberg LG, Magnusson M. Estimation of delivered dialysis dose by on-line monitoring of the ultraviolet absorbance in the spent dialysate. Am. J. Kidney Dis.41(5), 1026–1036 (2003).
  • Scherbakov A, Fridolin I. Dialysis Adequacy On-Line Monitoring Using DiaSens Optical Sensor: Technique and Clinical Application. Katashev A, Dekhtyar Y, Spigulis J (Eds). NBC Proceedings, US Government Print, Washington DC, USA 20, 323–326 (2008).
  • Uhlin F, Fridolin I, Magnusson M, Lindberg LG. Dialysis dose (Kt/V) and clearance variation sensitivity using measurement of ultraviolet-absorbance (on-line), blood urea, dialysate urea and ionic dialysance. Nephrol. Dial. Transplant.21(8), 2225–2231 (2006).
  • Uhlin F, Pettersson J, Fernström A, Lindberg LG. Complementary parameter for dialysis monitoring based on UV absorbance. Hemodial. Int.13(4), 492–497 (2009).
  • Santoro A, Mancini E, Zucchelli P. The impact of haemofiltration on the systemic cardiovascular response. Nephrol. Dial. Transplant.15(Suppl. 2), 49–54 (2000).
  • Rubinger D, Revis N, Pollak A et al. Predictors of haemodynamic instability and heart rate variability during haemodialysis. Nephrol. Dial. Transplant.19(8), 2053–2060 (2004).
  • Kamath V, Fallen EL. Power spectral analysis of heart rate variability: a noninvasive signature of cardiac autonomic function.’ Crit. Rev. Biomed. Eng.21(3), 245–311 (1993).
  • Bianchi AM, Mainardi LT, Meloni C et al. Continuous monitoring of the sympatho-vagal balance through spectral analysis. IEEE Eng. Med. Biol. Mag.16 (5), 64–73 (1997).
  • Mackey MC, Milton JG. Dynamical diseases. Ann. NY Acad. Sci.504, 16–32 (1987).
  • Kleiger RE, Stein PK, Bosner MS, Rottman JN. Time domain measurements of heart rate variability. Cardiol. Clin.10(3), 487–498 (1992).
  • Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Circulation93, 1043–1065 (1996).
  • Lombardi F, Malliani A, Pagani M, Cerutti S. Heart rate variability and its sympatho-vagal modulation. Cardiovasc. Res.32(2), 208–216 (1996).
  • Barnas MG, Boer WH, Koomans HA. Hemodynamic patterns and spectral analysis of heart rate variability during dialysis hypotension, J. Am. Soc. Nephrol.10(12), 2577–2584 (1999).
  • Pelosi G, Emdin M, Carpeggiani C et al. Impaired sympathetic response before intradialytic hypotension: a study based on spectral analysis of heart rate and pressure variability. Clin. Sci. (Lond.)96(1), 23–31 (1999).
  • Copie X, Hnatkova K, Staunton A, Fei L, Camm AJ, Malik M. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study. J. Am. Coll. Cardiol.27, 270–276 (1996).
  • La Rovere MT, Pinna GD, Maestri R et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation107, 565–570 (2003).
  • Lombardi F, Sandrone G, Pernpruner S et al. Heart rate variability as an index of sympathovagal interaction after acute myocardial infarction. Am. J. Cardiol.60, 1239–1245 (1987).
  • Chan CT. Heart rate variability in patients with end-stage renal disease: an emerging predictive tool for sudden cardiac death? Nephrol. Dial. Transplant.23, 3061–3062 (2008).
  • Sassi R, Cerutti S, Hnatkova K et al. HRV scaling exponent identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone. IEEE Trans. Biomed. Eng.53, 103–110 (2006).
  • Cerutti S, Esposti F, Ferrario M, Sassi R, Signorini MG. Long-term invariant parameters obtained from 24-h Holter recordings: a comparison between different analysis techniques. Chaos17(1), 015108 (2007).
  • Peng CK, Havlin S, Stanley HE, Goldberger AL. Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series. Chaos5, 82–87 (1995).
  • Fukuta H. Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis. Nephrol. Dial. Transplant.18, 318–325 (2003).
  • Cerutti S, Bianchi AM, Reiter H. Analysis of sleep and stress profiles from biomedical signal processing in wearable devices. Conf. Proc. IEEE Eng. Med. Biol. Soc. (Suppl.), 6530–6532 (2006).
  • Mendez MO, Bianchi AM, Matteucci M, Cerutti S, Penzel T. Sleep apnea screening by autoregressive models from a single ECG lead. IEEE Trans. Biomed. Eng.56(12), 2838–2850 (2009).
  • Gura V, Ronco C, Davenport A. The wearable artificial kidney, why and how: from holy grail to reality. Semin. Dial.22(1), 13–17 (2009).
  • Cerutti S, Magenes G, Bonato P. Guest editorial special section on smart wearable devices for human health and protection. IEEE Trans. Inf. Technol. Biomed.14(3), 691–693 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.